Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt/β-catenin pathway
Taslim B. Shaikh, Madhusudhana Kuncha, Sai Balaji Andugulapati, Ramakrishna Sistla
Topics & Concepts
BleomycinPulmonary fibrosisIdiopathic pulmonary fibrosisEpithelial–mesenchymal transitionWnt signaling pathwayFibrosisCancer researchMedicineLungExtracellular matrixPathologyHydroxyprolineInternal medicineSignal transductionBiologyCell biologyChemotherapyCancerMetastasisInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational exposure and asthmaOccupational and environmental lung diseases